Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jirapat Vamananda

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nephrology (Carlton, Vic.)|March 30, 2026
Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapyJirapat Vamananda, Weerachai Chaijamorn, Taniya Charoensareerat, et al.
Journal of Critical Care|August 24, 2025
Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapySirichai Chusiri, Jirapat Vamananda, Dhakrit Rungkitwattanakul, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nephrology (Carlton, Vic.)|March 30, 2026
Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapyJirapat Vamananda, Weerachai Chaijamorn, Taniya Charoensareerat, et al.
Journal of Critical Care|August 24, 2025
Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapySirichai Chusiri, Jirapat Vamananda, Dhakrit Rungkitwattanakul, et al.
Pageof 1